Interest in psychedelics for personal development and trauma processing is growing. At the same time, there is much uncertainty: what is and isn't possible in the Netherlands, what does “legal” mean, and how does coaching with psychedelics relate to therapy in mental healthcare? In this article, we zoom in on the concept of “LSD analogues” and their use in guided sessions, with particular attention to safety, preparation, and integration for people with (complex) trauma. We explicitly distinguish between what is being investigated in scientific research, what people report in practice, and what you can practically do to reduce risks.
LSD, analogues, and the demand for 'legal' variants
Classical LSD (lysergic acid diethylamide) is banned in the Netherlands. Therefore, some providers and participants seek alternatives, such as so-called LSD analogues (for example, substances that are chemically related). In online discussions and some provider texts, it is often claimed that such analogues are (partially) converted into LSD in the body or can at least produce a comparable effect. Such statements require nuance: while data may be limited for specific substances, it is not always easy to verify how complete that conversion is, how predictable the dosage turns out, and how consistent the effects are per person.
It is also important to note that, in practice, “legal” is not a quality label. In itself, it says little about purity, dosage reliability, setting, screening, or professional competencies. For people with trauma, it is precisely that context that is often decisive for the degree of safety: not only the substance, but especially the set (mental state, expectations, coping capacity) and setting (environment, support, agreements, and aftercare).
Trauma and psychedelic sessions: why guidance is especially important
When people use the word “trauma,” they do not all mean the same thing. It can refer to a single, significant event, but also to prolonged insecurity, attachment issues, or complex trauma. Psychedelic experiences can be intense and sometimes evoke unexpected emotions, memories, or physical stress reactions. This is not necessarily negative, but without proper guidance, it can become overwhelming.
Therefore, a number of elements are generally important in trauma-sensitive guidance, regardless of the method:
1) Screening and contraindications: A thorough intake examines psychological vulnerabilities, medication, safety in daily life, and support resources. This is not a formality, but a basic prerequisite for reducing risks.
2) Stabilization and preparation: With trauma, “going deep” is not always the goal. Sometimes it is actually safer to first work on grounding, emotion regulation, and recognizing boundaries.
3) Clear frameworks: agreements regarding physical safety, consent, dealing with touch, privacy, and what to do in case of panic or dissociation.
4) Integration: Translating an experience into concrete steps in daily life. Without integration, insights can fade or even linger in a confusing state.
Coaching, therapy, and scientific research: three different domains
Scientific research investigates whether and how psychedelics can contribute to psychological complaints, including trauma-related complaints. Research protocols often contain strict selection criteria, medical monitoring, and standardized treatment methods. This does not automatically make research “better,” but it is a different context than a commercial or private practice.
In addition, there is a field of practice in which people seek guidance for personal development or processing difficult experiences. This is sometimes referred to as “psychedelic coaching.” It is important to phrase this carefully: coaching is not the same as recognized medical treatment, nor is it a guarantee of improvement. Personal stories can be hopeful, but by definition, they remain personal and not automatically generalizable.
For MDMA, that context is particularly relevant. Currently, MDMA sessions can only be discussed and approached within scientific research or in clinical practice via harm reduction. In practice, this means: no medical claims, no promise of treatment outcomes, and a strong focus on safety, screening, and integration.
Safety and harm reduction during intense psychedelic experiences
Harm reduction means acknowledging that people may use psychedelics, and then minimizing risks as much as possible. That is different from promotion. In sessions with LSD-like substances, duration and intensity can be important factors. A long trip can be taxing if someone becomes tired, has not eaten enough, or experiences insufficient capacity to regulate emotions.
Practical harm-reduction themes that often recur:
Dosage uncertainty: With analogues, dosage reliability is not always easy to estimate. “Taking more” does not always work linearly and can make an experience unnecessarily intense.
Set & setting: a quiet, safe space, a sober facilitator, and pre-discussed scenarios (what if someone wants to stop, becomes frightened, or dissociates).
Contraindications: Certain mental disorders, instability, or combination with some medications can pose additional risks. This requires a professional intake and sometimes the advice not to use.
Integration plan: Schedule time after the session without obligations, including sleep, nutrition, and a follow-up conversation. Trauma integration can take weeks.
What we can and cannot say about effectiveness in trauma
It is understandable that people search for “does this work for trauma?”. The honest answer is that the outcome can vary greatly from person to person and context to context. Scientific research into psychedelics for trauma is evolving, with promising signs in specific settings, but that is not the same as certainty for everyone. Moreover, an intense experience can also lead to difficult after-effects, such as heightened sensitivity, sleep problems, or a period of emotional instability.
Therefore, caution is warranted regarding large claims. What is often sensible to investigate, however, is whether someone is ready for an intensive process, whether there is sufficient support in daily life, and whether a foundation of therapeutic skills (such as grounding and self-regulation) already exists.
Practical orientation: questions you can ask before you get on board
Anyone considering a guided psychedelic session with a background of trauma may benefit from critical questions, such as:
What screening is performed and what are the reasons for refusing someone?
What does preparation look like, and how many contact points are there before the session?
Who facilitates the session, what is their training, and what is their role during difficult moments?
Is there an integration process, and how are post-reactions handled?
What boundaries and safety agreements exist regarding consent, touch, and privacy?
These types of questions help to look beyond the label “legal” or “therapeutic” and assess whether the approach is truly careful.
Conclusion
“Trauma therapy with legal LSD analogues” is a subject that requires precision. LSD itself is prohibited, and claims regarding analogues and effectiveness are not always easy to verify. Apart from the substance, the most important factor often remains the quality of screening, preparation, guidance, and integration, especially in cases of trauma. Those wishing to delve deeper into working responsibly with psychedelics can also read the forum article to which this discussion frequently refers for context: LSD therapy – It can be done as coaching with legal variants.
If you are particularly interested in a carefully structured program with an emphasis on safety, screening, and integration surrounding MDMA in a harm-reduction context, you can explore your options further via sign up for an MDMA session. In addition, it should be noted that MDMA sessions can currently only be discussed and approached via harm reduction within scientific research or in practice, and there are no guarantees regarding outcomes.
English 
Dutch 
German 
French